Symbol="DYN"
AssetType="Common Stock"
Name="Dyne TherapeuticsÂ Inc"
Description="Dyne Therapeutics, Inc., a muscle disease company, is a biotechnology company focused on advancing therapeutics for genetically-derived muscle diseases in the United States. The company is headquartered in Waltham, Massachusetts."
CIK="1818794"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="830 WINTER STREET, WALTHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="633837000"
EBITDA="-178972992"
PERatio="None"
PEGRatio="0.19"
BookValue="4.149"
DividendPerShare="0"
DividendYield="0"
EPS="-3.32"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.334"
ReturnOnEquityTTM="-0.611"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-3.32"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="30.57"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.237"
EVToRevenue="-"
EVToEBITDA="-1.895"
Beta="0.119"
num_52WeekHigh="15.63"
num_52WeekLow="8.04"
num_50DayMovingAverage="12.24"
num_200DayMovingAverage="12.05"
SharesOutstanding="58311000"
DividendDate="None"
ExDividendDate="None"
symbol="DYN"
open="11.05"
high="11.14"
low="10.78"
price="10.87"
volume="369457.00"
latest_trading_day="2023-07-21"
previous_close="10.99"
change="-0.12"
change_percent="-1.0919%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="52"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="48"
Volume_recent_avg="484030"
Change_recent_avg="-0.03"
Delta_recent_avg="0.83"
Variance_recent_avg="0.41"
Change_ratio_recent_avg="-0.32"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="48"
Aroon_momentum_negative="52"
image_negative_thumbnail_id_1="1157"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_negative_thumbnail_id_2="1142"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0175.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="542"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_positive_thumbnail_id_1="949"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0111.jpeg"
image_positive_thumbnail_id_2="706"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0002.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
